Advertisement
Screener

Itron, Inc. (ITRI) Spending and interest coverage

Itron, Inc. (ITRI) Spending and interest coverage

  • R&D / revenue · 12 months: Value 9.30%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
  • Stock-based compensation / revenue · 12 months: Value 2.66%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
  • Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..

Spending and interest coverage

Overview →

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
R&D / revenue · 12 months9.30%Research and development expense / revenue. Period ending 2026-06-30.

$214.28M ÷ $2.30B × 100 ≈ 9.30%

Stock-based compensation / revenue · 12 months2.66%Share-based compensation / revenue. Period ending 2026-06-30.

$61.37M ÷ $2.30B × 100 ≈ 2.66%

Interest coverage · 12 months(m)Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Research and development spending214.28M USDResearch and Development Expense
Revenue2.30B USDRevenue from Contract with Customer, Excluding Assessed Tax
Stock-based compensation61.37M USDShare-based Payment Arrangement, Noncash Expense
Operating income304.08M USDOperating Income (Loss)
Interest expense · reported / estimated(m)Interest Expense · Estimated expense assumptions

Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingResearch and development spending (USD)Revenue (USD)Stock-based compensation (USD)Operating income (USD)Interest expense · reported / estimated (USD)R&D / revenueSBC / revenueInterest coverageInterest expense basis
2026-06-30$214.28M$2.30B$61.37M$304.08M(m)9.30%2.66%(m)(m)
2026-03-31$211.95M$2.35B$65.96M$304.43M(m)9.03%2.81%(m)(m)
2025-12-31$207.04M$2.37B$62.45M$313.07M(m)8.75%2.64%(m)(m)
2025-09-30$212.28M$2.41B$59.63M$297.14M(m)8.81%2.48%(m)(m)
2025-06-30$213.48M$2.44B$55.42M$289.29M(m)8.74%2.27%(m)(m)
2025-03-31$212.72M$2.44B$49.00M$277.52M(m)8.70%2.00%(m)(m)
2024-12-31$215.03M$2.44B$43.87M$264.11M(m)8.81%1.80%(m)(m)
2024-09-30$210.61M$2.41B$39.89M$250.65M$11.66M8.76%1.66%21.50×Reported
2024-06-30$211.02M$2.35B$36.51M$231.61M$8.50M8.98%1.55%27.25×Reported
2024-03-31$211.52M$2.28B$32.87M$202.06M$8.19M9.27%1.44%24.69×Reported
2023-12-31$208.69M$2.17B$28.36M$128.87M$8.35M9.60%1.30%15.44×Reported
2023-09-30$201.40M$2.06B$25.00M$91.98M$8.27M9.76%1.21%11.12×Reported
2023-06-30$193.57M$1.92B$23.04M$43.98M$7.51M10.06%1.20%5.86×Reported
2023-03-31$185.07M$1.81B$22.67M$-24.65M$7.19M10.20%1.25%-3.43×Reported
2022-12-31$185.10M$1.80B$21.88M$-7.44M$6.72M10.31%1.22%-1.11×Reported
2022-09-30$188.33M$1.81B$22.78M$-127.29M$6.46M10.38%1.26%-19.70×Reported
2022-06-30$191.40M$1.88B$23.56M$-130.01M$7.41M10.18%1.25%-17.54×Reported
2022-03-31$195.10M$1.94B$23.25M$-103.42M$19.75M10.07%1.20%-5.24×Reported
2021-12-31$197.24M$1.98B$23.62M$-79.30M$28.64M9.95%1.19%-2.77×Reported
2021-09-30$192.48M$2.02B$22.67M$60.77M$37.34M9.52%1.12%1.63×Reported
2021-06-30$191.82M$2.07B$22.06M$32.63M$45.52M9.25%1.06%0.72×Reported
2021-03-31$192.05M$2.09B$23.07M$-5.83M$43.20M9.17%1.10%-0.13×Reported
2020-12-31$194.10M$2.17B$25.05M$-10.39M$44.00M8.93%1.15%-0.24×Reported
2020-09-30$200.65M$2.28B$26.53M$-14.13M$46.33M8.81%1.17%-0.31×Reported
2020-06-30$205.04M$2.36B$28.76M$49.28M$48.38M8.68%1.22%1.02×Reported
2020-03-31$205.49M$2.49B$28.24M$138.23M$50.20M8.26%1.14%2.75×Reported
2019-12-31$202.20M$2.50B$26.96M$132.68M$52.45M8.08%1.08%2.53×Reported
2019-09-30$196.16M$2.46B$29.26M$132.34M$53.78M7.97%1.19%2.46×Reported
2019-06-30$192.78M$2.43B$28.43M$134.57M$55.09M7.92%1.17%2.44×Reported
2019-03-31$198.11M$2.38B$30.37M$111.58M$56.23M8.31%1.27%1.98×Reported
2018-12-31$207.91M$2.38B$31.26M$-49.69M$58.20M8.75%1.32%-0.85×Reported
2018-09-30$206.03M$2.34B$29.22M$-33.46M$45.83M8.81%1.25%-0.73×Reported
2018-06-30$201.25M$2.23B$27.89M$-36.91M$35.12M9.02%1.25%-1.05×Reported
2018-03-31$189.49M$2.15B$24.29M$-19.85M$23.89M8.82%1.13%-0.83×Reported
2017-12-31$169.98M$2.02B$21.41M$151.43M$11.58M8.42%1.06%13.08×Reported
2017-09-30$166.66M$1.96B$19.99M$134.98M$11.05M8.49%1.02%12.21×Reported
2017-06-30$163.49M$1.98B$20.29M$104.03M$10.85M8.24%1.02%9.59×Reported
2017-03-31$163.73M$1.99B$19.35M$102.68M$10.70M8.21%0.97%9.59×Reported
2016-12-31$168.21M$2.01B$18.04M$96.21M$10.95M8.36%0.90%8.79×Reported
2016-09-30$164.02M$2.01B$16.51M$81.83M$11.30M8.14%0.82%7.24×Reported
2016-06-30$166.19M$1.98B$13.97M$102.36M$11.40M8.41%0.71%8.98×Reported
2016-03-31$166.16M$1.93B$13.88M$62.92M$12.53M8.59%0.72%5.02×Reported
2015-12-31$162.33M$1.88B$14.09M$52.85M$12.29M8.62%0.75%4.30×Reported
2015-09-30$171.19M$1.90B$16.04M$-12.30M$12.10M9.02%0.85%-1.02×Reported
2015-06-30$171.93M$1.92B$16.40M$-23.05M$12.32M8.93%0.85%-1.87×Reported
2015-03-31$172.61M$1.94B$17.38M$12.83M$11.38M8.88%0.89%1.13×Reported
2014-12-31$175.50M$1.97B$17.86M$3.83M$11.60M8.91%0.91%0.33×Reported
2014-09-30$177.55M$1.98B$17.28M$-96.09M$12.00M8.95%0.87%-8.01×Reported
2014-06-30$176.74M$1.98B$18.18M$-119.04M$11.83M8.91%0.92%-10.06×Reported
2014-03-31$176.22M$1.98B$18.34M$-132.99M$11.26M8.92%0.93%-11.81×Reported
2013-12-31$176.02M$1.95B$18.85M$-135.18M$10.69M9.03%0.97%-12.65×Reported
2013-09-30$173.54M$1.95B$19.47M$33.31M$10.04M8.91%1.00%3.32×Reported
2013-06-30$175.35M$1.96B$20.38M$85.77M$9.75M8.96%1.04%8.80×Reported
2013-03-31$178.50M$2.05B$20.41M$113.85M$10.02M8.69%0.99%11.37×Reported
2012-12-31$178.65M$2.18B$19.51M$151.13M$10.12M8.20%0.90%14.94×Reported
2012-09-30$176.45M$2.30B$18.33M$71.55M$10.06M7.68%0.80%7.11×Reported
2012-06-30$171.53M$2.41B$16.15M$-471.67M$18.30M7.12%0.67%-25.77×Reported
2012-03-31$166.74M$2.44B$15.63M$-469.65M$27.12M6.83%0.64%-17.32×Reported
2011-12-31$162.53M$2.43B$16.41M$-459.18M$36.79M6.68%0.67%-12.48×Reported
2011-09-30$160.18M$2.41B$17.29M$-355.44M$47.02M6.64%0.72%-7.56×Reported
2011-06-30$155.54M$2.37B$19.50M$200.74M$49.55M6.56%0.82%4.05×Reported
2011-03-31$147.63M$2.33B$19.51M$202.67M$52.09M6.35%0.84%3.89×Reported
2010-12-31$140.23M$2.26B$19.11M$184.20M$54.90M6.21%0.85%3.35×Reported
2010-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2010-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2010-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2009-12-31$122.31M$1.69B$16.98M$45.03M$70.31M7.25%1.01%0.64×Reported
2009-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2009-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2008-12-31$120.70M$1.91B$16.58M$109.82M$94.18M6.32%0.87%1.17×Reported

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
AEHR TEST SYSTEMS (AEHR)United States$3.176B-420.65
COHU INC (COHU)United States$3.015B-82.78
ALLIENT INC (ALNT)United States$1.913B61.10
FREQUENCY ELECTRONICS INC (FEIM)United States$0.952B236.51
TRANSCAT INC (TRNS)United States$0.805B250.33
INTEST CORP (INTT)United States$0.146B291.94
ScanTech AI Systems Inc. (STAI)United States$0.069B-2.69
DATA I/O CORP (DAIO)United States$0.030B-4.65
Veralto Corp (VLTO)United States$23.619B22.32
TERADYNE, INC (TER)United States$60.595B59.25